S&P 500   4,688.09 (+2.10%)
DOW   35,742.14 (+1.46%)
QQQ   397.76 (+2.99%)
AAPL   170.74 (+3.28%)
MSFT   334.84 (+2.65%)
FB   323.83 (+1.87%)
GOOGL   2,935.51 (+2.53%)
AMZN   3,540.00 (+3.29%)
TSLA   1,046.83 (+3.75%)
NVDA   320.58 (+6.73%)
BABA   125.30 (+1.38%)
NIO   33.18 (+2.60%)
CGC   10.80 (+6.40%)
AMD   144.71 (+4.06%)
GE   97.96 (+2.03%)
MU   86.49 (+4.90%)
T   23.09 (-0.82%)
F   19.86 (+3.33%)
DIS   150.24 (-0.09%)
PFE   51.47 (-0.02%)
AMC   31.10 (+8.02%)
ACB   6.42 (+7.54%)
BA   210.42 (+2.21%)
S&P 500   4,688.09 (+2.10%)
DOW   35,742.14 (+1.46%)
QQQ   397.76 (+2.99%)
AAPL   170.74 (+3.28%)
MSFT   334.84 (+2.65%)
FB   323.83 (+1.87%)
GOOGL   2,935.51 (+2.53%)
AMZN   3,540.00 (+3.29%)
TSLA   1,046.83 (+3.75%)
NVDA   320.58 (+6.73%)
BABA   125.30 (+1.38%)
NIO   33.18 (+2.60%)
CGC   10.80 (+6.40%)
AMD   144.71 (+4.06%)
GE   97.96 (+2.03%)
MU   86.49 (+4.90%)
T   23.09 (-0.82%)
F   19.86 (+3.33%)
DIS   150.24 (-0.09%)
PFE   51.47 (-0.02%)
AMC   31.10 (+8.02%)
ACB   6.42 (+7.54%)
BA   210.42 (+2.21%)
S&P 500   4,688.09 (+2.10%)
DOW   35,742.14 (+1.46%)
QQQ   397.76 (+2.99%)
AAPL   170.74 (+3.28%)
MSFT   334.84 (+2.65%)
FB   323.83 (+1.87%)
GOOGL   2,935.51 (+2.53%)
AMZN   3,540.00 (+3.29%)
TSLA   1,046.83 (+3.75%)
NVDA   320.58 (+6.73%)
BABA   125.30 (+1.38%)
NIO   33.18 (+2.60%)
CGC   10.80 (+6.40%)
AMD   144.71 (+4.06%)
GE   97.96 (+2.03%)
MU   86.49 (+4.90%)
T   23.09 (-0.82%)
F   19.86 (+3.33%)
DIS   150.24 (-0.09%)
PFE   51.47 (-0.02%)
AMC   31.10 (+8.02%)
ACB   6.42 (+7.54%)
BA   210.42 (+2.21%)
S&P 500   4,688.09 (+2.10%)
DOW   35,742.14 (+1.46%)
QQQ   397.76 (+2.99%)
AAPL   170.74 (+3.28%)
MSFT   334.84 (+2.65%)
FB   323.83 (+1.87%)
GOOGL   2,935.51 (+2.53%)
AMZN   3,540.00 (+3.29%)
TSLA   1,046.83 (+3.75%)
NVDA   320.58 (+6.73%)
BABA   125.30 (+1.38%)
NIO   33.18 (+2.60%)
CGC   10.80 (+6.40%)
AMD   144.71 (+4.06%)
GE   97.96 (+2.03%)
MU   86.49 (+4.90%)
T   23.09 (-0.82%)
F   19.86 (+3.33%)
DIS   150.24 (-0.09%)
PFE   51.47 (-0.02%)
AMC   31.10 (+8.02%)
ACB   6.42 (+7.54%)
BA   210.42 (+2.21%)
NYSEAMERICAN:XTNT

Xtant Medical Stock Forecast, Price & News

$0.72
+0.01 (+1.37%)
(As of 12/7/2021 11:20 AM ET)
Add
Compare
Today's Range
$0.70
$0.72
50-Day Range
N/A
52-Week Range
$0.65
$6.58
Volume
344 shs
Average Volume
1.45 million shs
Market Capitalization
$62.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.48
30 days | 90 days | 365 days | Advanced Chart
Receive XTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for Xtant Medical and its competitors with MarketBeat's FREE daily newsletter.


Xtant Medical logo

About Xtant Medical

Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. Thecompany was founded in 2006 and is headquartered in Belgrade, MT.

Headlines

See More Headlines

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:XTNT
Employees
110
Year Founded
N/A

Sales & Book Value

Annual Sales
$53.34 million
Book Value
$0.38 per share

Profitability

Net Income
$-7.02 million
Pretax Margin
-5.33%

Debt

Price-To-Earnings

Miscellaneous

Free Float
86,213,000
Market Cap
$62.43 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/12/2021
Today
12/07/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/22/2022

MarketRank

Overall MarketRank

1.29 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Xtant Medical (NYSEAMERICAN:XTNT) Frequently Asked Questions

Are investors shorting Xtant Medical?

Xtant Medical saw a decline in short interest in November. As of November 15th, there was short interest totaling 197,600 shares, a decline of 21.7% from the October 31st total of 252,500 shares. Based on an average trading volume of 140,900 shares, the days-to-cover ratio is presently 1.4 days. Currently, 1.9% of the company's stock are short sold.
View Xtant Medical's Short Interest
.

When is Xtant Medical's next earnings date?

Xtant Medical is scheduled to release its next quarterly earnings announcement on Tuesday, February 22nd 2022.
View our earnings forecast for Xtant Medical
.

How were Xtant Medical's earnings last quarter?

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) released its earnings results on Friday, November, 12th. The medical device company reported ($0.02) earnings per share (EPS) for the quarter. The medical device company earned $13.78 million during the quarter. Xtant Medical had a negative trailing twelve-month return on equity of 11.44% and a negative net margin of 5.92%.
View Xtant Medical's earnings history
.

When did Xtant Medical's stock split? How did Xtant Medical's stock split work?

Xtant Medical shares reverse split on Wednesday, February 14th 2018. The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 13th 2018. An investor that had 100 shares of Xtant Medical stock prior to the reverse split would have 8 shares after the split.

Who are Xtant Medical's key executives?

Xtant Medical's management team includes the following people:
  • Sean E. Browne, President, Chief Executive Officer & Director
  • Gregory P. Jensen, Chief Financial Officer & Vice President-Finance
  • Kevin D. Brandt, Chief Commercial Officer & Senior Vice President
  • Stephen C. Smith, VP-Regulatory Affairs & Quality Assurance

What other stocks do shareholders of Xtant Medical own?

What is Xtant Medical's stock symbol?

Xtant Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XTNT."

Who are Xtant Medical's major shareholders?

Xtant Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Altium Capital Management LP (7.21%) and Renaissance Technologies LLC (0.79%).
View institutional ownership trends for Xtant Medical
.

Which major investors are selling Xtant Medical stock?

XTNT stock was sold by a variety of institutional investors in the last quarter, including Altium Capital Management LP, and Renaissance Technologies LLC.
View insider buying and selling activity for Xtant Medical
or view top insider-selling stocks.

How do I buy shares of Xtant Medical?

Shares of XTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Xtant Medical's stock price today?

One share of XTNT stock can currently be purchased for approximately $0.72.

How much money does Xtant Medical make?

Xtant Medical has a market capitalization of $62.43 million and generates $53.34 million in revenue each year. The medical device company earns $-7.02 million in net income (profit) each year or ($0.04) on an earnings per share basis.

How many employees does Xtant Medical have?

Xtant Medical employs 110 workers across the globe.

What is Xtant Medical's official website?

The official website for Xtant Medical is xtantmedical.com.

Where are Xtant Medical's headquarters?

Xtant Medical is headquartered at 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States.

How can I contact Xtant Medical?

Xtant Medical's mailing address is 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States. The medical device company can be reached via phone at (406) 388-0480, via email at [email protected], or via fax at 406-388-1354.


This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.